NASDAQ Companies

CINCINNATI, Feb. 14, 2024 (GLOBE NEWSWIRE) — GRIID Infrastructure Inc. (Nasdaq: GRDI) (“GRIID” or the “company”), a vertically integrated bitcoin […]

MESA, Ariz., Feb. 14, 2024 (GLOBE NEWSWIRE) — Nxu Inc. (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company developing […]

BALA CYNWYD, Pa., Feb. 14, 2024 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused […]

SYDNEY, Australia, Feb. 14, 2024 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (together with its subsidiaries, “Iris Energy” or […]

Seoul, Feb. 14, 2024 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of […]

STAFFORD, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused […]

Austin, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) — Acri Capital Acquisition Corporation (the “Company”) (Nasdaq: ACAC), a special purpose acquisition […]

VANCOUVER, British Columbia, Feb. 14, 2024 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse […]

In the AdFIrst study, Biotest’s fibrinogen concentrate (FC), BT524, met the primary endpoint, demonstrating its effectiveness in treating acquired fibrinogen […]

LONDON, Feb. 14, 2024 (GLOBE NEWSWIRE) — For the fourth consecutive year, leading global data analytics and technology provider Verisk […]